These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37889110)

  • 1. Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis.
    Gangwani MK; Ahmed Z; Ishtiaq R; Aziz M; Rani A; Dahiya DS; Priyanka F; Arif SF; Lee-Smith W; Sohail AH; Inamdar S; Hassan M
    Minerva Gastroenterol (Torino); 2024 Sep; 70(3):353-358. PubMed ID: 37889110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.
    Dai R; Sag AA; Martin JG; Befera NT; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Muir AJ; Ronald J
    Clin Imaging; 2021 Sep; 77():187-192. PubMed ID: 33940357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Lewis DS; Lee TH; Konanur M; Ziegler C; Hall MD; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Choi SS; Ronald J
    J Vasc Interv Radiol; 2019 Feb; 30(2):163-169. PubMed ID: 30638914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a systematic review and meta-analysis.
    Su Y; Chen Y; Zheng J; Yao C
    BMJ Open; 2024 Apr; 14(4):e078412. PubMed ID: 38569689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
    Shi D; Zhou Z; Dai Y; Pan X; Cao Q
    Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS).
    Sturm L; Bettinger D; Giesler M; Boettler T; Schmidt A; Buettner N; Thimme R; Schultheiss M
    United European Gastroenterol J; 2018 Nov; 6(9):1380-1390. PubMed ID: 30386611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.
    Bai M; Qi X; Yang Z; Yin Z; Nie Y; Yuan S; Wu K; Han G; Fan D
    J Gastroenterol Hepatol; 2011 Jun; 26(6):943-51. PubMed ID: 21251067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A systematic review and meta-analysis.
    Yang M; Qiu Y; Wang W
    Dig Liver Dis; 2024 Jun; 56(6):978-985. PubMed ID: 37926635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.
    Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1765-1772. PubMed ID: 29872892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
    Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
    World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis.
    Ma YJ; Cao ZX; Li Y; Feng SY
    World J Gastroenterol; 2019 Jun; 25(21):2675-2682. PubMed ID: 31210718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between sarcopenia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review and meta-analysis.
    Li Y; Guo Y; Wang X; Gao L
    Abdom Radiol (NY); 2024 Feb; 49(2):575-585. PubMed ID: 37980601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic Status Is Associated with the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Helzberg JH; Dai R; Muir AJ; Wilder J; Lee TH; Martin JG; Kim CY; Ronald J
    J Vasc Interv Radiol; 2021 Jul; 32(7):950-960.e1. PubMed ID: 33663923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.
    Li M; Li K; Tang S; Lv Y; Wang Q; Wang Z; Luo B; Niu J; Zhu Y; Guo W; Bai W; Wang E; Xia D; Wang Z; Li X; Yuan J; Yin Z; Trebicka J; Han G
    JHEP Rep; 2022 May; 4(5):100448. PubMed ID: 35313729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.